European markets traded slightly lower Thursday afternoon as investors react to news of a potentially effective coronavirus treatment while monitoring corporate earnings and economic data.
Proactive planning can aid you in achieving short- and long-term financial needs and goals, especially in times of hardship like the current coronavirus pandemic.
As countries across Europe start to lift their lockdowns, close attention is being paid to the so-called "R" rate as an indication of whether a second wave of coronavirus infections could be on the horizon.
The euro zone took a sharp hit to its economy in the first quarter, data released Thursday shows, and everyone is talking about the coronavirus' infection rate as lockdowns are slowly lifted.
Pharmaceutical giant AstraZeneca has partnered with Oxford University to help develop and distribute the vaccine being researched by the Jenner Institute and Oxford Vaccine Group.
Almost half of the world's wealthy investors and business owners expect to maintain their stock portfolio at the same level for the next six months, according to a study by UBS.
After weeks of record unemployment claims across the country, "we have seen a couple of indicators of some bottoming," ADP CEO Carlos Rodriguez told CNBC.
"This drug makes a big difference, especially if you were worried about a second wave of infections after we reopened the economy," the "Mad Money" host said.